From triazolophthalazines to triazoloquinazolines: A bioisosterism-guided approach toward the identification of novel PCAF inhibitors with potential anticancer activity

Mohamed H. El‐Shershaby, Adel Ghiaty, Ashraf H. Bayoumi, +4

Bioorganic & Medicinal Chemistry

Medicinal ChemistryBiochemistryNovel Pcaf InhibitorsMedicineBioisosterism-guided Approach +9

Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA)

Mohamed M. Elsebaei, Haroon Mohammad, Mohamed Abouf, +9

European Journal of Medicinal Chemistry

Methicillin-resistant Staphylococcus AureusAntibioticsMedicineAlkynyl-containing PhenylthiazolesAntibacterial Agent +5

Novel triazolophthalazine-hydrazone hybrids as potential PCAF inhibitors: Design, synthesis, in vitro anticancer evaluation, apoptosis, and molecular docking studies

Hamada S. Abulkhair, Abdallah Turky, Adel Ghiaty, +2

Bioorganic Chemistry

Combinatorial ChemistryMedicinal ChemistryPotential Pcaf InhibitorsMedicineVitro Anticancer Evaluation +7

Synthesis and Evaluation of Some New (1,2,4) Triazolo(4,3‐a)Quinoxalin‐4(5H)‐one Derivatives as AMPA Receptor Antagonists

Hamada S. Abulkhair, Salwa Elmeligie, Ashraf H. Bayoumi, +3

Journal of Heterocyclic Chemistry

Molecular PharmacologyMedicinal ChemistryDerivative (Chemistry)DerivativesDiversity Oriented Synthesis +13

Investigating the Antibacterial Activity of Biphenylthiazoles against Methicillin- and Vancomycin-Resistant <i>Staphylococcus aureus</i> (MRSA and VRSA)

Mohamed Hagras, Haroon Mohammad, Mohamed S. Mandour, +4

Journal of Medicinal Chemistry

Design, synthesis, and antitumor activity of novel compounds based on 1,2,4-triazolophthalazine scaffold: Apoptosis-inductive and PCAF-inhibitory effects

Abdallah Turky, Ashraf H. Bayoumi, Adel Ghiaty, +3

Bioorganic Chemistry

Medicinal Chemistry1,2,4-Triazolophthalazine ScaffoldAntitumor ActivityPcaf-inhibitory EffectsMedicine +7

1,2,4-Triazolo[4,3-<i>c</i>]quinazolines: a bioisosterism-guided approach towards the development of novel PCAF inhibitors with potential anticancer activity

Mohamed H. El‐Shershaby, Adel Ghiaty, Ashraf H. Bayoumi, +4

New Journal of Chemistry

Novel Pcaf InhibitorsPotential Anticancer ActivityPharmacotherapyPharmaceutical ChemistryTumor Biology +23

In vivo‐ and in silico‐driven identification of novel synthetic quinoxalines as anticonvulsants and AMPA inhibitors

Hamada S. Abulkhair, Salwa Elmeligie, Adel Ghiaty, +8

Archiv der Pharmazie

Design, synthesis, and molecular docking studies of new [1,2,4]triazolo[4,3-a]quinoxaline derivatives as potential A2B receptor antagonists

Hany G. Ezzat, Ashraf H. Bayoumi, Farag F. Sherbiny, +4

Molecular Diversity

Combinatorial ChemistryMedicinal ChemistryMedicineNatural SciencesPharmacological Agent +4

Synthesis and Biological Evaluation of Some [1,2,4]Triazolo[4,3-<i>a</i>]quinoxaline Derivatives as Novel Anticonvulsant Agents

Mohamed Alswah, Adel Ghiaty, Ahmed El-morsy, +1

ISRN Organic Chemistry

Medicinal ChemistryPharmaceutical ChemistryDerivative (Chemistry)MedicinePharmacological Agent +8